Since kinase specificity plays a major role in cancer development, protein kinase-targeted drugs have emerged as the most efficient way of cancer treatment, and currently more than 70 drugs based on tyrosine inhibition are used for several cancer treatments (Cohen et al., 2021). This evidence concerns the gene WEE1 and cancer.